Stay updated on Oral Etrasimod for Eosinophilic Esophagitis Clinical Trial
Sign up to get notified when there's something new on the Oral Etrasimod for Eosinophilic Esophagitis Clinical Trial page.

Latest updates to the Oral Etrasimod for Eosinophilic Esophagitis Clinical Trial page
- Check6 days agoChange DetectedThe clinical trial record for the etrasimod study is now displayed, including its design, eligibility criteria, outcomes, locations, publications, and data-sharing details, replacing the access-denied page.SummaryDifference100%

- Check13 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0. The study record page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA site-wide notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check27 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check34 days agoChange DetectedThe footer site revision changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check55 days agoChange DetectedA new revision tag Revision: v3.7.0 was added. Several user-facing items such as the contact information prompt and links to study documents were removed, altering how users locate contact details and access study materials.SummaryDifference16%

Stay in the know with updates to Oral Etrasimod for Eosinophilic Esophagitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Etrasimod for Eosinophilic Esophagitis Clinical Trial page.